Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning

Journal:

Science Advances

Published:

2025-06-06

DOI:

10.1126/sciadv.adt5708

Affiliations:

12

Authors:

28

Go to article

Institutions	Authors	Share
University of California, San Francisco (UCSF), United States of America (USA)	12.000000 12.000000	0.43
Duke University Health System, United States of America (USA)	8.000000	0.29
Michigan Medicine, U-M, United States of America (USA)	2.000000	0.07
Harvard Medical School (HMS), United States of America (USA)	1.000000	0.04
University of California, Los Angeles (UCLA), United States of America (USA)	1.000000	0.04
Mayo Clinic, United States of America (USA)	1.000000	0.04
University of Michigan (U-M), United States of America (USA)	1.000000	0.04
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.04
UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC), United States of America (USA)	1.000000	0.04

Interested in Policy and Administration?